Anti-snoring Treatment Market – By Device, By Distribution Channel, Global Forecast, 2025 to 2034

Anti-snoring Treatment Market Size

The global anti-snoring treatment market size was valued at around USD 1.5 billion in 2024 and is estimated to grow at 8.5% CAGR from 2025 to 2034. Anti-snoring treatments aim to reduce or eliminate snoring. Snoring happens when airflow through the throat and nasal passages is partially blocked during sleep, causing nearby tissues to vibrate. These treatments target the root causes of snoring, which can include nasal congestion, poor sleep posture, obesity, or anatomical issues like a deviated septum or enlarged tonsils.
 

The rising prevalence of sleep disorders is poised to fuel the growth of the global anti-snoring treatment market in the coming years. Sleep disorders can significantly impact both the quality and duration of sleep. Statistics from the Parliament of Australia highlight the issue: one in five Australians grapples with a major sleep disorder. Furthermore, chronic and severe snoring can lead to serious health issues, including sleep apnea, breathing obstructions, and certain cardiovascular conditions. Thus, as sleep disorder cases rise, so too will the demand for anti-snoring treatments.
 

Additionally, aging is a primary factor that exacerbates snoring. For example, the Asia Pacific region, as reported by the Economic and Social Commission for Asia and the Pacific (ESCAP), boasts over 630 million individuals aged 60 and above, accounting for 60% of the global elderly demographic. As individuals age, weight accumulation around the neck narrows the throat, and changes in sleeping habits and relaxed throat muscles during sleep further heighten the risk of snoring. Given the growing elderly population worldwide, the demand for anti-snoring devices is set to surge in the coming years.
 

Anti-snoring Treatment Market Trends

• The increasing prevalence of sleep disorders, particularly obstructive sleep apnea (OSA), is a significant driver of the market. As awareness of the health risks associated with untreated sleep apnea grows, more individuals are seeking diagnosis and treatment options.
   
• Technological advancements in anti-snoring devices are revolutionizing the market. Smart devices equipped with sensors and mobile app connectivity allow users to track their sleep patterns and adjust treatments accordingly. These innovations are making anti-snoring solutions more effective and user-friendly.
   
• The rise of home sleep testing is making diagnosis more accessible and convenient for patients. This trend is reducing barriers to entry for potential anti-snoring treatment users and expanding the market reach.
   
• Personalized medicine approaches are gaining traction in the market. Customized solutions, such as 3D-printed mandibular advancement devices, are being developed to provide more effective and comfortable treatments tailored to individual patient needs.
   
• Non-invasive treatments are becoming increasingly popular among patients seeking alternatives to traditional surgical interventions. This trend is driving the development and adoption of mandibular advancement devices, nasal dilators, and positional therapy devices.
   
• The growing focus on the relationship between snoring, sleep quality, and overall health is expanding the market beyond traditional medical channels. Wellness and lifestyle-oriented anti-snoring solutions are emerging, appealing to a broader consumer base concerned with improving their sleep and general well-being.
   
• Hence, telemedicine and remote patient monitoring are facilitating better follow-up care and treatment adherence. These technologies are enabling healthcare providers to adjust treatments more efficiently and improve long-term outcomes for patients using anti-snoring devices, thus leading to market growth.
   

Anti-snoring Treatment Market Analysis

In the market, devices are categorized into mandible advancement devices, tongue stabilizing devices, nasal devices, continuous positive airway pressure (CPAP) devices, chin straps, and other devices. The CPAP devices segment led the market with a revenue of USD 426.3 million in 2024 and is expected to grow at a significant CAGR during the forecast period.
 

• CPAP devices are the standard treatment for obstructive sleep apnea (OSA) and snoring. With the increasing prevalence of these conditions, the adoption of CPAP devices is expected to rise, driving market growth. According to the National Council on Aging, nearly 39 million adults in the U.S. currently suffer from obstructive sleep apnea. CPAP devices effectively treat moderate to severe sleep apnea, contributing to their market growth.
   
• CPAP therapy keeps airways open by delivering a continuous stream of air through a mask worn during sleep. These devices improve airway function, promote restful sleep, and increase consumer preference for this technology. The continuous airflow helps users achieve better sleep, enhancing the appeal of CPAP devices.
   
• Rising awareness of sleep disorders and the proven effectiveness of CPAP therapy are expected to drive segment growth in the coming years. As more people understand the importance of treating sleep apnea and related conditions, the demand for CPAP devices is likely to grow, supporting the market's expansion.
   

Based on distribution channel, the anti-snoring treatment market is segmented into hospitals, clinics, retail pharmacies, e-commerce, and other distribution channels. The e-commerce segment dominated the market in 2024 and is expected to grow significantly to reach USD 1.1 billion by 2034.
 

• The growing trend in product purchases through online channels, increasing internet penetration, and easy access to a broad range of anti-snoring devices and products that can be ordered from home have led to the dominance of e-commerce as a distribution channel for anti-snoring devices. This is especially important for people who may be uncomfortable discussing snoring issues in person due to social stigma.
   
• Moreover, online platforms often offer a greater variety of anti-snoring solutions than retail pharmacies or clinics, including specialized devices like chin straps, CPAP masks, and nasal dilators. This variety allows consumers to find specific products tailored to their needs.
   

In 2024, the U.S. led the North American anti-snoring treatment market, generating USD 559 million, and is expected to see significant growth during the forecast period.
 

• In the U.S., growing awareness about sleep disorders and their health impacts is driving the market. As Americans increasingly recognize the importance of quality sleep for overall health, the demand for effective snoring solutions is rising. This trend is further supported by increasing obesity rates—a major risk factor for snoring—and an aging population more prone to sleep-related issues.
   
• Technological advancements have expanded the market by introducing non-invasive and user-friendly anti-snoring devices and treatments. These innovations appeal to consumers seeking alternatives to traditional, often invasive, snoring remedies.
   
• Broader healthcare coverage for sleep-related treatments has also made anti-snoring solutions more accessible. For example, Medicare covers CPAP devices for treating Obstructive Sleep Apnea (OSA).
   
• These factors have created a favorable environment for the U.S. market. As healthcare providers and consumers prioritize sleep health, the demand for effective snoring solutions continues to grow. This trend is expected to persist, supported by ongoing research, technological advancements, and a focus on preventive healthcare.
   

From 2025 to 2034, France's anti-snoring treatment market is expected to grow significantly.
 

• In France, increasing awareness and improved diagnosis of sleep disorders, especially obstructive sleep apnea (OSA), are driving market growth. As more people seek medical help for snoring and related conditions, the demand for solutions like CPAP devices and mandibular advancement devices (MADs) is rising.
   
• Additionally, sedentary lifestyles, poor diets, and high alcohol and tobacco consumption are contributing to rising obesity rates, which are closely linked to snoring. A survey by C3 Collaborating for Health shows that one in six adults in France is obese, highlighting a significant health concern.
   

Between 2025 and 2034, the Asia Pacific anti-snoring treatment market is anticipated to grow significantly.
 

• Several factors are driving the growth of the market in the Asia Pacific. Increasing awareness of sleep disorders and their health impacts has boosted demand for effective solutions. Rising obesity rates and sleep apnea, particularly among the aging population, are also creating significant market opportunities.
   
• Technological advancements in anti-snoring devices have expanded the range of options available to consumers. At the same time, rising disposable incomes in many Asia Pacific countries have increased healthcare spending, including on sleep-related treatments like sleep apnea devices, further driving market growth.
   

From 2025 to 2034, South Africa's market is expected to grow significantly.
 

• In South Africa, rising obesity rates are a key factor driving the growth of the anti-snoring treatment market.
   
• Excess weight is a known risk factor for snoring, as it can narrow airways during sleep. As obesity rates increase, more individuals are seeking anti-snoring treatments, boosting market growth. According to the Human Sciences Research Council, about 50% of adults in South Africa are overweight or obese, indicating a large potential market for anti-snoring devices.
   
• Additionally, the prevalence of respiratory diseases in South Africa has increased awareness and demand for anti-snoring solutions, as people look to improve respiratory health and reduce sleep disruptions caused by snoring.
   
• These factors are expected to drive the growth of South Africa's market in the coming years.
   

Anti-snoring Treatment Market Share

The market is highly competitive, with numerous players offering a diverse range of products and solutions. Leading companies, such as ResMed and Philips, compete based on factors like product efficacy, innovation, pricing, and distribution networks. Innovation plays a crucial role in maintaining a competitive advantage, with companies investing in research and development to introduce advanced technologies, such as smart devices with monitoring capabilities and more comfortable designs. The competitive landscape is also influenced by regulatory factors, as companies strive to meet stringent quality and safety standards. As awareness about sleep disorders increases, the market is expected to witness further competition and innovation in the coming years.
 

Anti-snoring Treatment Market Companies

Some of the eminent market participants operating in the anti-snoring treatment industry include:

• AccuMED 
• Airing
• Airway Management
• Apnea Sciences
• Fisher & Paykel Healthcare
• GlaxoSmithKline
• Illusion Aligners
• Koninklijke Philips
• Meditas
• ResMed
• Sleeping Well
• SomnoMed
• The Pure Sleep Company
• Tomed
• Vyaire Medical  
   

Anti-snoring Treatment Industry News:

• In May 2023, Illusion Aligners launched an innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps users experience undisturbed and peaceful sleep every night. The strategy helped the company expand its product portfolio and sustain its position in the market. 
   

The anti-snoring treatment market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in terms of units from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Device

• Mandible advancement devices
• Tongue stabilizing devices
• Nasal devices
• Continuous positive airway pressure devices
• Chin straps
• Other devices

Market, By Distribution Channel

• Hospitals
• Clinics
• Retail pharmacies
• E-commerce
• Other distribution channels

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France           
  • Spain
  • Italy
  • Russia
  • Poland
  • Switzerland
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Thailand
  • Indonesia 
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Israel